Delivery Order SPE2DB20D2014-SPE2DB25FD03Z
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 13, 2025, valued at $2,595.83 for the supply of Viscoat syringes (0.5mL) to support federal medical procurement needs. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. The award falls under the Defense Logistics Agency's Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viscoat syringes (0.5ml) valued at $27,117.66. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will take place at the...
- The Defense Logistics Agency awarded a $2,628.99 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Viscoat syringes (0.5mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,853.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,045.04 by the Defense Logistics Agency's Medical Supply Chain on August 17, 2025. This non-competitive delivery order represents a firm fixed price contract with an ultimate completion date of August 18, 2025, and is classified as a child contract under a larger indefinite delivery vehicle. The award demonstrates AmerisourceBergen's continued role...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded delivery order (Contract No. 4569285368) is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery vehicle, this award represents one of numerous...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, valued at $4,863.93 with a firm fixed price contract type. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,635.42 on September 8, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $12,162.43 from the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a non-competitive set-aside award with a completion deadline of August 12, 2025. The contract supports federal medical procurement needs, consistent...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD03ZDelivery Order
On September 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,640.14 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringe 0.5ML medical devices. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 19, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with the Defense Logistics Agency. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the vehicle enabling this and similar delivery orders. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical devices to support military and veteran healthcare systems worldwide. The company's federal contract portfolio encompasses specialty medications, vaccines, syringes, and medical supplies across multiple therapeutic areas, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/18/25 |